Reiko Ashida

Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Background Rapid on‐site evaluation enhances the diagnostic yield of endoscopic ultrasound‐guided fine needle aspiration (EUS‐FNA), but the cytopathologists are limited. This study aimed to assess the diagnostic capability of an artificial intelligence‐assisted ROSE (AI‐ROSE) for EUS‐FNA. Methods The study included 137 patients who underwent EUS‐FNA of a pancreatic mass between April 2019 and August 2021. Participants were divided into training ( n = 96), validation ( n = 15), and test cohorts ( n = 26). From the training/validation cohort, 5157/615 digital images of cell clusters were extracted and divided into 288 × 288‐pixel patches. These cell clusters were annotated and labeled into five classes. A semantic segmentation architecture was developed. From the test cohort, 120 cell clusters were extracted to compare diagnostic performance between AI‐ROSE and 21 endosonographers and 5 cytotechnologists with varying experience levels in ROSE. Results In total, 1,097,840 training, 31,817 validation, and 1920 test regions were extracted. In the test cohort, AI‐ROSE accuracy for three‐category classification (class 1/2, class 3, and class 4/5) was 89.8%. For two‐category classification (class 1/2/3 and class 4/5), sensitivity, specificity, and accuracy were 89.3%, 98.1%, and 95.1%, respectively. In the comparison cohort, AI‐ROSE accuracy for two‐category classification was 93.3%, significantly higher than all endosonographers (68.3%; range, 45.8%–86.7%) and cytotechnologists (76.3%; range, 72.5%–78.3%). The AI‐ROSE evaluation time for 120 cell clusters was 6.04 s, much shorter than that of all endosonographers (1800; 480–6000 s) and cytotechnologists (2160; 1020–3600 s). Conclusions The AI‐ROSE model shows remarkable speed and accuracy in diagnosing pancreatic cell clusters, enabling rapid decision‐making during EUS‐FNA. UMIN‐CTR; No. 000042212.

Year:

2025

Objectives Detective flow imaging endoscopic ultrasonography (DFI‐EUS) is a recent imaging modality developed for detecting fine vessels without the need for ultrasound contrast agents. The aim of the present study was to evaluate the utility of DFI‐EUS for solid pancreatic lesions and to compare the diagnostic ability for pancreatic cancer (PC) between DFI‐EUS, directional power Doppler (eFLOW) EUS, and contrast‐enhanced harmonic (CH)‐EUS. Methods Patients with a pancreatic lesion who underwent DFI‐EUS, eFLOW‐EUS, and CH‐EUS between March 2019 and November 2023 were retrospectively enrolled. Final diagnoses were confirmed by pathologic examination of EUS‐guided tissue acquisition and/or resected specimens. Lesions were categorized into the three patterns of poor, mild, and rich vascularity on DFI‐EUS and eFLOW‐EUS, and hypo‐, iso‐, and hypervascular on CH‐EUS. PC was defined as a poor pattern on DFI‐EUS and eFLOW‐EUS, and a hypovascular pattern on CH‐EUS. Results The final diagnoses of 90 examined tumors were PC ( n = 57), inflammatory mass ( n = 6), autoimmune pancreatitis ( n = 13), neuroendocrine tumor ( n = 9), and others ( n = 5). The sensitivity, specificity, and accuracy for diagnosis of PC were 93%, 82%, and 88%, respectively, on DFI‐EUS, 97%, 42%, and 77% on eFLOW‐EUS, and 95%, 89%, and 92% on CH‐EUS. The accuracy of DFI‐EUS was significantly superior to eFLOW‐EUS ( P = 0.005), but no significant difference was found between DFI‐EUS and CH‐EUS. Conclusion DFI‐EUS is more sensitive for depicting vasculature than eFLOW‐EUS, and has higher diagnostic sensitivity for PC. Evaluation of vascularity on DFI‐EUS is useful for the differential diagnosis of pancreatic lesions without the need for intravenous contrast agent.

Year:

2024

Background and study aims The relative procedural performance of needles for endoscopic ultrasound-guided fine-needle aspiration/biopsy (EUS-FNA/B) is unclear. The present study therefore compared six types of 22-gauge FNA/B needles using a bench simulator. Methods Resistance forces during needle puncture and removal, needle tip damage before and after procedure, leakage after puncture of mucinous cyst models, the shape of the puncture surface at the puncture site, amounts of samples extracted, ranges of needle deflection angles, and needle deformation after multiple procedures were compared using six types of needles. Results Maximum resistance forces during puncture and removal were highest for ProCore needles and lowest for Expect needles. None of the needles had damage after puncturing. SharkCore needles showed the highest amount of leakage, whereas FNA needles showed no leakage. The puncture tracts of FNA needles remained in the form of a flap at the puncture site, whereas FNB needles broke off the target material creating a hole. The target material removed was supplemented within the puncture needle. TopGain needles produced significantly larger samples than ProCore, EZShot3 Plus, and Expect needles. FNB needles produced larger and more core samples than FNA needles. EZShot3 Plus needles had the highest range of needle deflection angle using an elevator device and the lowest needle deformation after 20 punctures at full endoscopic angle and a full elevator. Conclusions The performance of the six needles differed in various ways. Understanding the characteristics of each needle may allow for selection of the appropriate needle for each situation.

Year:

2024

A variety of devices have been developed for interventional endoscopic ultrasound (EUS). EUS‐guided drainage of the bile duct and pancreatic duct, as well as fluid collection adjacent to the gastrointestinal tract, is performed by a procedure involving puncture, guidewire manipulation, tract dilation, and stent placement. Devices specialized for interventional EUS are being developed for each step of the procedure. Mechanical dilators such as bougie, balloon, and electrocautery dilators are used for tract dilation. Various types of plastic stents, self‐expandable metal stents, and lumen‐apposing metal stents specifically designed for interventional EUS are now available, including one‐step devices developed to improve the efficacy and safety of interventional EUS. In addition, radiofrequency ablation and the placement of fiducial markers and radioactive seeds under EUS guidance are now becoming established for pancreatic neoplasms. Such development of specialized devices has expanded the indications for interventional EUS, increased the success rate, and lowered the adverse event rate.

Year:

2022

Collaborators (3)

Masahiro Itonaga

Assistant Professor

Wakayama Medical University

JAPAN
View details

Kazuo Hara

Director

Aichi Cancer Center

JAPAN
View details

Masayuki Kitano

Professor

Wakayama Medical University

JAPAN
View details